Dublin, Ireland, and Seraing, Belgium – ERS Genomics Limited and Syngulon, a synthetic biology startup developing original genetic technologies using bacteriocins, announced today a non-exclusive license agreement which provides Syngulon with worldwide access to ERS’ CRISPR-Cas9 genome editing intellectual property for use in combination with Syngulon Patent Rights. ERS Genomics holds rights to the foundational CRISPR-Cas9 […]

Quantum Analytics Enters into Distribution Agreement with Bruker AXS for Benchtop XRF and XRD Products in the United States Foster City, California – Quantum Analytics is excited to announce that it has entered into a distribution agreement with Bruker AXS, a global market leader in advanced X-ray solutions for materials research and quality control in […]

BC Platforms, a world leader in genomic data management and analytics today announced it is launching its world leading genomics platform for HUS, the Hospital District of Helsinki and Uusimaa and the largest Healthcare service provider in the whole Nordics region. BC Platforms will be providing its customizable end-to-end Software-as-a-Service platform to provide actionable reports […]

HOUSTON–Genialis, which provides AI-driven, platform-enabled data integration solutions to help accelerate drug discovery, today announced a partnership with Roche to provide researchers with a complete, streamlined next-generation sequencing (NGS) workflow for gene expression profiling. By using Genialis, Roche KAPA RNA HyperPrep Kit* customers now have end-to-end support from sample through analysis. Genialis and Roche are […]

Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology  Daresbury, UK: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a technology access agreement with Teleflex Incorporated, a New York Stock Exchange listed company (NYSE: TFX). Teleflex will harness Arcis’ advanced nucleic acid sample preparation chemistry in the […]

Genialis’ single-click visual analytics solution complements single-day RNA-seq library preparation HOUSTON–Genialis, which provides AI-driven, platform-enabled data integration solutions to help accelerate drug discovery, today announced a partnership with Roche to provide researchers with a complete, streamlined next-generation sequencing (NGS) workflow for gene expression profiling. By using Genialis, Roche KAPA RNA HyperPrep Kit* customers now have […]

PALO ALTO, Calif. — Genoox announced today it is partnering with Microsoft Healthcare to bring its Microsoft Genomics service to Genoox’s global customers to help advance precision medicine. Genoox specializes in translating complex genetic data into clear, timely, and actionable clinical answers via purpose-built genetic applications. Combining the performance and scalability of Microsoft’ Genomics’ world-class Azure cloud with […]

Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partnership for Microsoft   LONDON — The data scientists and developers behind a ground-breaking microbiome data platform, today, announced their partnership with Microsoft Genomics, a Microsoft Azure service dedicated to meeting the computational challenges of the genomics era. […]

Distributor will supply Chirascan circular dichroism spectrometers and SX stopped-flow spectrometers to Ireland and Northern Ireland Surrey, UK and Dublin, IRELAND: Applied Photophysics, a leading provider of systems for biophysical characterization of biomolecules, today announced that it has signed a distribution agreement with material characterisation specialist, Particular Sciences. The distributor will supply industry and researchers in both […]

MILPITAS, Calif.–Applied StemCell, Inc. (ASC), a leading gene-editing company, announced that it has joined the National Institute of Standards and Technology (NIST) Genome Editing Consortium. Applied StemCell brings to the Consortium its expertise in TARGATT™ CRISPR/Cas9 gene-editing tools and induced pluripotent stem cell (iPSC) technology for the advancement of drug discovery and therapeutic applications. As part […]